Erratum: Newborn Screening for Galactosemia in the United States: Looking Back, Looking Around, and Looking Ahead (JIMD Reports, (2014) 15, 10.1007/8904_2014_302);Newborn screening for galactosemia in the united states: looking back, looking around, and looking ahead

JIMD Reports

Volumn 15, Issue , 2015, Pages 79-93

  Pyhtila, Brook M ^a   Shaw, Kelly A ^b   Neumann, Samantha E ^b   Fridovich Keil, Judith L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Classic galactosemia; Galt activity; Newborn screen; Newborn screening; Total galactose

Indexed keywords

EID: 85060307451     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_369     Document Type: Erratum

References (38)

1. Alano A, Almashanu S, Maceratesi P, Reichardt J, Panny S, Cowan TM (1997) UDP-galactose-4-epimerase deficiency among African-Americans: evidence for multiple alleles. J Investig Med 45:191A
2. Berry G (2012) Galactosemia: when is it a newborn screening emergency? Mol Genet Metab 106:7–11
3. Beutler E, Baluda M (1966) A simple spot screening test for galactosemia. J Lab Clin Med 68:137–141
4. Carney A, Sanders R, Garza K et al (2009) Origins, distribution and expression of the Duarte-2 (D2) allele of galactose-1-phosphate uridylyltransferase. Hum Mol Genet 18:1624–1632
5. Coffee B, Hjelm L, DeLorenzo A, Courtney E, Yu C, Muralidharan K (2006) Characterization of an unusual deletion of the galactose-1-phosphate uridyl transferase (GALT) gene. Genet Med 8:635–640
6. Dobrowolski S, Banas R, Suzow J, Berkley M, Naylor E (2003) Analysis of common mutations in the galactose-1-phosphate uridyl transferase gene: new assays to increase the sensitivity and specificity of newborn screening for galactosemia. J Mol Diagn 5:42–47
7. Elsas LJ, Lai K, Saunders CJ, Langley SD (2001) Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 72:297–305
8. Fernhoff PM (2010) Duarte galactosemia: how sweet is it? Clin Chem 56:1045–1046
9. Ficicioglu C, Thomas N, Yager C et al (2008) Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening. Mol Genet Metab 95:206–212
10. Freer D, Ficicioglu C, Finegold D (2010) Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach. Clin Chem 56:437–444
11. Fridovich-Keil JL, Walter JH (2008) Galactosemia. In: Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, Ballabio A (eds) The online metabolic & molecular bases of inherited disease. McGraw Hill, http://www.ommbid.com
12. Fridovich-Keil JL, Bean L, He M, Schroer R (2011) Epimerase deficiency galactosemia. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (eds) GeneReviews™ [Inter-net]. University of Washington, Seattle, 1993–2013, http://www. ncbi.nlm.nih.gov/books/NBK51671
13. Gethins M (2012) Breast cancer in men. J Natl Cancer Inst 104:436–438
14. Greber S, Guldberg P, Scheibenreiter S, Strobl W (1995) Mutations in classical and Duarte2 galactosemia. Pediatr Res 38:434 (abstract)
15. Gurian E, Kinnamon D, Henry J, SEW (2006) Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117:1915–1921
16. Hennermann J, Schadewaldt P, Vetter B, Shin Y, Mönch E, Klein J (2011) Features and outcome of galactokinase deficiency in children diagnosed by newborn screening. J Inherit Metab Dis 34:399–407
17. Janzen N, Illsinger S, Meyer U et al (2011) Early cataract formation due to galactokinase deficiency: impact of newborn screening. Arch Med Res 42:608–612
18. Kalaydjieva L, Perez-Lezaun A, Angelicheva D et al (1999) A founder mutation in the GK1 gene is responsible for galactokinase deficiency in Roma (Gypsies). Am J Hum Genet 65:1299–1307
19. Leslie ND, Immerman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ (1992) The human galactose-1-phosphate uridyl transferase gene. Genomics 14:474–480
20. Levy H, Sepe S, Walton D et al (1978) Galactose-1-phosphate uridly transferase deficiency due to Duarte/galactosemia combined variation: clinical and biochemical studies. J Pediatr 93:390
21. Mellman WJ, Tedesco TA, Feigl P (1968) Estimation of the gene frequency of the Duarte variant of galactose-1-phosphate uridyl transferase. Ann Hum Genet 32:1–8
22. Mohamad H, Apffelstaedt J (2008) Counseling for male BRCA mutation carriers – a review. Breast 17:441–450
23. Ohlsson A, Guthenberg C, von Döbeln U (2012) Galactosemia screening with low false-positive recall rate: the Swedish experience. JIMD Rep 2:113–117
24. Ono H, Mawatari H, Mizoguchi N, Eguchi T, Sakura N, Hamakawa M (1999) Transient galactosemia detected by neonatal mass screening. Pediatr Int 41:281–284
25. Ono H, Mawatari H, Mizoguchi N, Eguchi T, Sakura N, Hamakawa M (2000) Delay of liver maturation as a cause of transient neonatal galactosemia. Pediatr Int 42:61–63
26. Openo K, Schulz J, Vargas C et al (2006) Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet 78:89–102
27. Podskarbi T, Kohlmetz T, Gathof BS et al (1996) Molecular characterization of Duarte-1 and Duarte-2 variants of galactose-1-phosphate uridyltransferase. J Inher Metab Dis 19:638–644
28. Powell KK, Van Naarden BK, Singh RH, Shapira SK, Olney RS, Yeargin-Allsopp M (2009) Long-term speech and language developmental issues among children with Duarte galactosemia. Genet Med 11:874–879
29. Raffel LJ, Cowan TM, Blitzer MG (1993) Transient neonatal galactosemia identified by newborn screening. J Inher Metab Disorders 16:894–895
30. Riehman K, Crews C, Fridovich-Keil JL (2001) Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276:10634–10640
31. Sangiuolo F, Magnani M, Stambolian D, Novelli G (2004) Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency. Hum Mutat 23:396–396
32. Suzuki M, West C, Beutler E (2001) Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. Hum Genet 109:210–215
33. Tighe O, Flanagan JM, Kernan F et al (2004) Frequency distribution of the Los Angeles and Duarte galactose-1-phosphate uridyltransferase variant alleles in the Irish population. Mol Genet Metab 82:345–347
34. 0 upstream region of the GALT gene reduces promoter efficiency. Hum Genet 109:117–120
35. Tyfield LA (2000) Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype. Eur J Pediatr 159(Suppl 3):S204–S207
36. van Calcar S, Bernstein L (2011) Nutrition management of classical and Duarte galactosemia: results from an international survey (Abstract). J Inherit Metab Dis 102:262 (Abstract P489)
37. Walter JH, Roberts REP, Besley GTN et al (1999) Generalised uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child 80:374–376
38. Wilcken B (2013) Newborn screening: gaps in the evidence. Science 342:197–198